410 Results for "

mu

" in MedChemExpress (MCE) Product Catalog:
Products (410)

410 Results for "mu" in MCE Product Catalog:

74
74 Publications Verification
Cat. No.: HY-19707
CAS No.: 14003-96-4
Synonyms: IRE1 Inhibitor III
Target:  

IRE1

Research Areas:  

Metabolic Disease

4μ8C (IRE1 Inhibitor III) is a small-molecule inhibitor of IRE1α.
loading...
    loading...
22
22 Cited Publications
Cat. No.: HY-10940
CAS No.: 64984-31-2
Purity:  99.66%
Synonyms: PFTμ; 2-Phenylethynesulfonamide
Target:  

MDM-2/p53 HSP Autophagy

Research Areas:  

Neurological Disease Cancer

Pifithrin-μ is an inhibitor of p53 and HSP70, with antitumor and neuroprotective activity.
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-15122
CAS No.: 115-53-7
Purity:  99.94%
Sinomenine, an alkaloid extracted from Sinomenium acutum, is a blocker of the NF-κB activation . Sinomenine also is an activator of μ-opioid receptor .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-15122A
CAS No.: 6080-33-7
Purity:  99.89%
Synonyms: Cucoline hydrochloride
Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from Sinomenium acutum, is a blocker of the NF-κB activation . Sinomenine also is an activator of μ-opioid receptor .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-P81140
Synonyms: 8-hydroxy-2'-deoxyguanosine; 2'-Deoxy-8-oxoguanosine; 7,8-Dihydro-8-oxo-2'-deoxyguanosine; 8-Oxo-7,8-dihydro-2'-deoxyguanosine; 8-Oxo-7,8-dihydrodeoxyguanosine; 2'-Deoxy-8-oxo-D-guanosine; 8-Oxo-7,8-dihydro-2μ-deoxyguanosine,8-Oxo-dG; 2'-Deoxy-8-hydroxyguanosine;

Host:  

Rabbit

Application:  

IHC-P, IHC-F, ELISA, IF-Tissue, mIHC

Reactivity:  

Species independent

loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-P0210
CAS No.: 78123-71-4
Target:  

Opioid Receptor

Research Areas:  

Cancer

DAMGO is a μ-opioid receptor (μ-OPR ) selective agonist with a Kd of 3.46 nM for native μ-OPR .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-P0210B
CAS No.: 950492-85-0
Target:  

Opioid Receptor

Research Areas:  

Cancer

DAMGO TFA is a μ-opioid receptor (μ-OPR ) selective agonist with a Kd of 3.46 nM for native μ-OPR .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-100529
CAS No.: 179528-45-1
Purity:  98.57%
Target:  

Proteasome

Research Areas:  

Cancer

PD 150606 is a selective, cell-permeable non-peptide calpain inhibitor with Ki values of 0.21 μM and 0.37 μM for μ- and m-calpains respectively, which is neuroprotective .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-156131
CAS No.: 53179-11-6
Synonyms: ADL 2-1294
Loperamide (ADL 2-1294) is selective and orally active μ opioid receptor agonist with Ki valuess of 3, 48 and 1156 nM against μ, δ and κ opioid receptor, respectively. Loperamide produces antinociception and antihyperalgesia. Loperamide exhibits peripheral selectivity, enhancing fluid, electrolyte, and glucose absorption, reversing PGE2 (HY-101952)- and Cholera toxin (HY-P1446)-induced intestinal secretion, and reducing intestinal motility. Loperamide can be used for the researches of inflammatory pain and protracted diarrhoea .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-100754
CAS No.: 1792180-81-4
Purity:  99.43%
Synonyms: PF-06651600
Research Areas:  

Inflammation/Immunology

Ritlecitinib (PF-06651600) is a highly selective, orally active, irreversible covalent JAK3 inhibitor (IC50=33 nM) without inhibitory activity towards JAK1, JAK2, and TYK2 (IC50 >10 μ M). Ritlecitinib rapidly inactivates the JAK3 kinase, and blocks signaling and downstream STAT phosphorylation mediated by common gamma chain cytokines such as IL-2 and IL-15. Ritlecitinib can inhibit Th1/Th17 cell differentiation and function, and effectively suppress preclinical animal models such as alopecia areata, adjuvant-induced arthritis (AIA), and experimental autoimmune encephalomyelitis (EAE) .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-100754C
CAS No.: 2192215-81-7
Purity:  99.77%
Synonyms: PF-06651600 tosylate
Research Areas:  

Inflammation/Immunology

Ritlecitinib (PF-06651600) tosylate is a highly selective, orally active, irreversible covalent JAK3 inhibitor (IC50=33 nM) without inhibitory activity towards JAK1, JAK2, and TYK2 (IC50 >10 μ M). Ritlecitinib tosylate rapidly inactivates the JAK3 kinase, and blocks signaling and downstream STAT phosphorylation mediated by common gamma chain cytokines such as IL-2 and IL-15. Ritlecitinib tosylate can inhibit Th1/Th17 cell differentiation and function, and effectively suppress preclinical animal models such as alopecia areata, adjuvant-induced arthritis (AIA), and experimental autoimmune encephalomyelitis (EAE) .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-N0187
CAS No.: 90-33-5
Synonyms: Hymecromone; 4-mu
4-Methylumbelliferone is a hyaluronic acid biosynthesis inhibitor with antitumoral and antimetastatic effects.
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-N0187A
CAS No.: 5980-33-6
Synonyms: Hymecromone sodium salt; 4-mu sodium salt
Research Areas:  

Cancer

4-Methylumbelliferone (sodium salt) is a coumarin derivative. 4-Methylumbelliferone (sodium salt) can be used as a standard to quantify the free 4-methylumbelliferone released as a result of enzyme-substrate action. 4-Methylumbelliferone (sodium salt) inhibits hyaluronan production in vitro. 4-Methylumbelliferone (sodium salt) can be studied in ovarian cancer research .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-N6771
CAS No.: 18172-33-3
Cyclopiazonic acid is an endoplasmic reticulum calcium ATPase (ECAs) inhibitor and human respiratory syncytial virus (RSV) inhibitor (EC50 value of 4.13 μ M), which can reduce the antagonistic effect of 5-HT receptors in rat thoracic aorta, induce p53 dependent cell apoptosis and reproductive toxicity in mouse testes, and inhibit the biological activation of aflatoxin B [1][4][5].
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-19749
CAS No.: 181765-30-0
PD 151746 is a selective calpain-1 inhibitor with an IC50 of 260 nM. PD 151746 binds μ-calpain Ca 2+-binding sites, and shows selectivity over cathepsin B, papain, trypsin, thermolysin, and basal calcineurin. PD 151746 reduces Oxidized low-density lipoprotein (oxLDL)-induced cytotoxicity, apoptotic DNA fragmentation, and blocks IL-1α maturation. PD 151746 can be used for the research of atherosclerosis and psoriasis .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-101386
CAS No.: 1997387-43-5
Purity:  99.46%
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P70270
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Glutathione S-transferase class-mu 26 kDa isozyme; EC:2.5.1.18; GST 26; Sj26 antigen; SjGST
Species:  
Source:  
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P0185
CAS No.: 189388-22-5
Endomorphin 1, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. Endomorphin 1 has antinociceptive properties .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P0185A
CAS No.: 1276123-71-7
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Endomorphin 1 acetate, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. Endomorphin 1 acetate has antinociceptive properties .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101302
CAS No.: 122517-78-6
Purity:  99.65%
Research Areas:  

Inflammation/Immunology

Naltriben mesylate is a potent δ2-opioid receptor antagonist and a TRPM7 activator. Naltriben mesylate shows Ki values of 0.013 nM, 19 nM and 152 nM for δ, μ and κ receptors, respectively. Naltriben mesylate enhances glioblastoma cell migration and invasion. Naltriben mesylate can be used in research into neurological diseases and cancer .
loading...
    loading...